Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 77 (RNA5SP77) is a genomic locus annotated as a pseudogene of the 5S ribosomal RNA gene family. Pseudogenes are DNA sequences similar to known genes but generally non-functional due to mutations, truncations, or lack of necessary regulatory elements[4][6]. rRNA pseudogenes such as RNA5SP77 do not encode functional ribosomal RNA and are not involved in ribosome biosynthesis or cellular physiology. There is no evidence of its involvement as a therapeutic target, biomarker, or disease gene, nor are there any known drugs that interact with or modulate its function. The annotation as a pseudogene rather than a functional gene or receptor, and lack of disease or drug data, indicate that this is not considered a biomedical target. The inclusion of “pseudogene” in its official name and molecular classification further confirms its non-target status and lack of biological or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 77 (RNA5SP77).